Early versus late acute antibody-mediated rejection in renal transplant recipients.
about
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsLate and chronic antibody-mediated rejection: main barrier to long term graft survivalUnraveling the Role of Allo-Antibodies and Transplant InjuryOne-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allograftsUtility of HLA Antibody Testing in Kidney Transplantation.Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.Expanding the antibody-mediated component of plasma cell-rich acute rejection: A case series.Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.The increasing clinical importance of alloantibodies in kidney transplantation.The need for minimization strategies: current problems of immunosuppression.Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survival.Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants.Current pathological perspectives on chronic rejection in renal allografts.mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: where are we now?Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab.Acute Antibody-Mediated Rejection in Renal Transplantation: Current Clinical Management.Acute Rejection in Renal Transplant Patients of a Hospital in Bogota, ColombiaBortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.Treatment of Antibody-Mediated Rejection After Kidney Transplantation - 10 Years' Experience With Apheresis at a Single Center.Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies.Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection.Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant.The time dependency of renal allograft histology.Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant.
P2860
Q26774993-93C1E5EA-FD95-4E06-8ACE-D1FDB1C2ABCCQ27006030-365A3E30-DB22-4E2F-BAAA-0D2FD487F319Q28069336-54D8B5E3-2021-48C4-82EF-F19673157015Q35565364-137D2233-84AC-403B-ADDF-D9A172B63329Q35790601-0FA38F6F-8A52-4472-9C00-3052C85AAE2DQ36822826-E1EA15BD-BB9F-4CEA-B39E-1B8DFFE8D73CQ36887183-8A94A836-BB9D-4792-96F1-1814E0AA339EQ37660263-F5482681-60B0-4865-ABF8-7F1C1CC2DC17Q38258153-DFABAAB4-D0D1-488B-882B-E234EEF2DC62Q38370826-08BB5685-5D2C-4634-A75D-D43A7DB093CEQ38429887-25DBFAF0-6E77-4638-B540-7DDA795352EAQ38699017-3A902285-208E-44EF-942A-86B1236F4B9AQ38795065-BFDEABA0-44C4-4024-9195-30C68FAC9C33Q38818479-D0956689-2882-40F8-81F4-8C36286DB4E5Q40149564-2B42AFE0-E338-48F1-8D63-1C0311C47EFEQ41118002-8257452B-4D7E-49E7-9D63-CD621A0B474DQ41358191-540E48FC-C836-431C-AA6C-DECD80E84F70Q41495990-B4F1A214-7B23-47E0-B6E6-FA4ACCA7154EQ42102593-D4D392C7-A63E-4224-BF63-C35E52B723FCQ47147931-F9F99658-F4E6-4A89-BA9D-51B810C9D695Q47286616-1AEDE7F3-FC4F-456A-8362-1B14132D43A3Q47409507-A5C1F712-2522-4422-84F0-42DAF00A8612Q48162490-B316DA81-5942-4743-9645-DBA7F55216AEQ53117621-408BA5C2-3FC7-4FFB-8C84-B584162F5FC7
P2860
Early versus late acute antibody-mediated rejection in renal transplant recipients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Early versus late acute antibody-mediated rejection in renal transplant recipients.
@en
Early versus late acute antibody-mediated rejection in renal transplant recipients.
@nl
type
label
Early versus late acute antibody-mediated rejection in renal transplant recipients.
@en
Early versus late acute antibody-mediated rejection in renal transplant recipients.
@nl
prefLabel
Early versus late acute antibody-mediated rejection in renal transplant recipients.
@en
Early versus late acute antibody-mediated rejection in renal transplant recipients.
@nl
P2093
P50
P1433
P1476
Early versus late acute antibody-mediated rejection in renal transplant recipients
@en
P2093
Anders Hartmann
Anna Varberg Reisæter
Christina Dörje
Erik H Strøm
Hallvard Holdaas
Jørn Petter Lindahl
Linda Flaa-Johnsen
Tommy Aronsen
Torbjørn Leivestad
Trond Jenssen
P356
10.1097/TP.0B013E31829434D4
P577
2013-07-01T00:00:00Z